Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-18-000879
Filing Date
2018-02-12
Accepted
2018-02-12 16:14:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 CATALYST BIOSCIENCES, INC. p18-0262sc13g.htm SC 13G 59589
  Complete submission text file 0000902664-18-000879.txt   61149
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82442 | Film No.: 18596519
SIC: 2834 Pharmaceutical Preparations

Mailing Address 120 WEST 45TH STREET SUITE 2802 NEW YORK NY 10036
Business Address 120 WEST 45TH STREET SUITE 2802 NEW YORK NY 10036 212-937-4975
venBio Select Advisor LLC (Filed by) CIK: 0001633313 (see all company filings)

EIN.: 271007403 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G